astrazeneca glp 1 pipeline Market Overview: GLP-1 Agonists and the Obesity Market | Blog Market Overview: GLP-1 Agonists and
Description
Patients have a choice between multiple effective weight loss options for the first time in many years.
The MHRA has updated its GLP-1 guidance due to a risk of the rare occurence of NAION among semaglutide patients
In clinical trials, GLP-1 RAs were shown to significantly lower blood pressure (BP) in addition to HbA1c and body weight (BW), indicating the possibility as anti-hypertensive medication of type 2 DM individuals
Learn how GLP-1/GIP weight loss may affect low T, estrogen, belly fat, and TRT
Is berberine a GLP-1 agonist
Learn more about the types, possible side effects, and more.
